COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information

Mauri D, Kamposioras K, Tsali L, Dambrosio M, De Bari B, Hindi N, Salembier C, Nixon J, Dimitrios T, Alongi F, Hameed H, Valachis A, Papadimitriou K, Corradini S, Popovic L, Kopecky J, Rodriguez A, Antunac K, Yi J, Lovey J, Strojan P, Saraireh H, Rotterud R, Chojnacka M, Olalla SC, Chilingirova N, De Mello RA, Amaral GA, Arbabi F, Vidra R, Rapushi E, Takeuchi D, Christopoulos C, Ivanova I, Djan I, Petricevic B, Cellini F, Mihaylova I, Plavetic ND, Kuhar CG, Takeuchi E, Kountourakis P, Ntellas P, Gazouli I, Gkoura S, Yuce S, Er Ö, Yasmina C, Kumaran G, Spahiu O, Yusuf A, Gono P, Apostolidis K, Tolia M (2022)

Publication Type: Journal article

Publication year: 2022

Journal

Book Volume: 17

Pages Range: 11-14

Journal Issue: 1

DOI: 10.2174/1574887116666211028145848

Abstract

Background: Covid-19 vaccination has started in the majority of the countries at the global level. Cancer patients are at high risk for infection, serious illness, and death from COVID-19 and need vaccination guidance and support. Guidance availability in the English language only is a major limit for recommendations’ delivery and their application in the world’s population and generates information inequalities across the different populations. Methods: Most of the available COVID-19 vaccination guidance for cancer patients was screened and scrutinized by the European Cancer Patients Coalition (ECPC) and an international oncology panel of 52 physicians from 33 countries. Results: A summary guidance was developed and provided in 28 languages in order to reach more than 70 percent of the global population. Conclusion: Language barrier and e-guidance availability in the native language are the most important barriers when communicating with patients. E-guidance availability in various native languages should be considered a major priority by international medical and health organizations that are communicating with patients at the global level.

Involved external institutions

University of Novi Sad Serbia (RS) Institute for Oncology Ljubljana (OIL) Slovenia (SI) Acıbadem Üniversitesi Turkey (TR) Zagreb University Hospital Centre / Klinički bolnički centar Zagreb (KBC) Croatia (HR) Maria Skłodowska-Curie Institute of Oncology / Centrum Onkologii–Instytut im. Marii Skłodowskiej-Curie w Warszawie Poland (PL) Christie NHS Foundation Trust United Kingdom (GB) Fondazione Policlinico Universitario Agostino Gemelli IRCCS Italy (IT) University Hospital of Ioannina / Panepistēmiakó Nosokomeío Iōannínōn / Πανεπιστημιακό Γενικό Νοσοκομείο Ιωαννίνων Greece (GR) Hospital of La Chaux-de-Fonds / Hôpital de la Chaux-de-Fonds Switzerland (CH) Federal University of São Paulo / Universidade Federal de São Paulo (UNIFESP) Brazil (BR) Berat Regional Hospital / Spitali Rajonal Berat Albania (AL) Semmelweis University / Semmelweis Egyetem Hungary (HU) Wiener Gesundheitsverbund Kliniken Austria (AT) Sisters of Charity Hospital / Klinički Bolnički Centar Sestre Milosrdnice (KBCSM) Croatia (HR) Mother Theresa University Hospital Center Albania (AL) Assistance Publique-Hôpitaux de Paris (AP-HP) France (FR) Hospital Universitario Fundación Jiménez Díaz Spain (ES) Groupe hospitalier intercommunal Le Raincy-Montfermeil (GHI Le Raincy Montfermeil) France (FR) University General Hospital of Heraklion Greece (GR) Università degli Studi di Brescia Italy (IT) University Clinical Centre of Serbia / Univerzitetski Klinički Centar Srbije / Универзитетски клинички центар Србије Serbia (RS) Peking Union Medical College / 北京协和医学院 China (CN) Medical University Pleven / Медицински университет - Плевен Bulgaria (BG) Bank of Cyprus Oncology Center Cyprus (CY) Moores Cancer Center United States (USA) (US) Cliniques de l’Europe / Europa Ziekenhuizen Belgium (BE) Matsudo City Hospital / 松戸市立病院 Japan (JP) Univerzita Karlova v Praze / Charles University in Prague Czech Republic (CZ) University of Strathclyde United Kingdom (GB) The Bladder Cancer Company Norway (NO) Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH) Pakistan (PK) Hospital Network Antwerp / Ziekenhuis Netwerk Antwerpen (ZNA) Belgium (BE) Clinica Polispecialistica San Carlo Italy (IT) Klinikum der Universität München (LMU Klinikum) Germany (DE)

How to cite

APA:

Mauri, D., Kamposioras, K., Tsali, L., Dambrosio, M., De Bari, B., Hindi, N.,... Tolia, M. (2022). COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information. Reviews on Recent Clinical Trials, 17(1), 11-14. https://doi.org/10.2174/1574887116666211028145848

MLA:

Mauri, Davide, et al. "COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information." Reviews on Recent Clinical Trials 17.1 (2022): 11-14.

BibTeX: Download